Downregulation of ITGA5 inhibits lymphangiogenesis and cell migration and invasion in male laryngeal squamous cell carcinoma
Protoplasma · 2023
DOI: 10.1007/s00709-023-01873-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protoplasma, 2023. Verfasst von Xiaoting Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, Fujian, China. Hauptthemen laut MEDLINE: Lymphangiogenesis, Laryngeal Neoplasms, Cell Movement, Down-Regulation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
ITGA5, a fibronectin receptor was highly expressed in laryngeal squamous cell carcinoma (LSCC) samples and was related to poor survival. However, the potential mechanism remains unclear. To elucidate the regulatory role of ITGA5 in LSCC progression, we investigated the effect of ITGA5 expression on lymphangiogenesis, migration, and invasion of LSCC cells in vitro and in vivo using immunohistochemistry, siRNA transfection, qRT-PCR, western blotting, enzyme-linked immunosorbent assay, flow cytometry, transwell co-culture, tube formation, cell migration, and invasion assays, and a subcutaneous graft tumor model. The expression of ITGA5 was higher in the LSCC tissues and linked to lymph node metastasis and T staging. Moreover, ITGA5 expression was significantly positively correlated with VEGF-C expression, and the lymphatic vessel density of patients with high ITGA5 expression was noticeably higher than that of patients with low ITGA5 expression. Additionally, it was found in vitro that downregulation of ITGA5 expression not only inhibited the expression and secretion of VEGF-C, but also suppressed the tube-forming ability of human lymphatic endothelial cells (HLECs) and the migration and invasion ability of LSCC cells, while exogenous VEGF-C supplementation reversed these phenomena. Furthermore, a tumor xenograft assay showed that si-ITGA5 restrained the growth and metastasis of TU212-derived tumors in vivo. Our findings suggested that ITGA5 induces lymphangiogenesis and LSCC cell migration and invasion by enhancing VEGF-C expression and secretion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Laboratory, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, Fujian, China.
- Department of Clinical Laboratory, Fujian Medical University Union Hospital, Fuzhou, China.
- Department of Pathology, Fujian Medical University Union Hospital, Fuzhou, China.
- Department of Otorhinolaryngology, Head and Neck Surgery, The 900th Hospital of the People's Liberation Army Joint Service Support Force, 156 North Xi-er Huan Road, Fuzhou, 350025, Fujian, China. puwenyang@163.com.
- Central Laboratory, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, Fujian, China. huanghuif@fjmu.edu.cn.
Zitieren
APA
Wang, X., Huang, J., You, R., Hou, D., Liu, J., Wu, L., Yao, M., Yang, F., & Huang, H. (2023). Downregulation of ITGA5 inhibits lymphangiogenesis and cell migration and invasion in male laryngeal squamous cell carcinoma. Protoplasma. https://doi.org/10.1007/s00709-023-01873-3
Vancouver
Wang X, Huang J, You R, Hou D, Liu J, Wu L, et al. Downregulation of ITGA5 inhibits lymphangiogenesis and cell migration and invasion in male laryngeal squamous cell carcinoma. Protoplasma. 2023. doi:10.1007/s00709-023-01873-3
BibTeX
@article{Wang2023,
author = {Wang, Xiaoting and Huang, Jun and You, Ruolan and Hou, Diyu and Liu, Jingru and Wu, Long and Yao, Meihong and Yang, Fuwen and Huang, Huifang},
title = {Downregulation of ITGA5 inhibits lymphangiogenesis and cell migration and invasion in male laryngeal squamous cell carcinoma},
journal = {Protoplasma},
year = {2023},
doi = {10.1007/s00709-023-01873-3}
}
EUVIMED